Clinical trial
Prognosis and Therapeutic Biomarkers for Glioblastoma Patients
NCT03403803 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognosis and Therapeutic Biomarkers for Glioblastoma Patients
- Lead sponsor
- Baylor Research Institute
- Phase
- Observational
- Overall status
- Terminated
- Start date
- September 1, 2017
- Completion date
- March 25, 2019
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.